Eurofins Amatsigroup
Abstract: As part of Quality by Design (QbD) principle, new tools allow the pharmaceutical industry to develop more robust analytical methods from the earliest stages of drug development. With a QbD strategy, the method will be close to its optimum and more robust versus a 'traditional' approach. This strategy has been implemented at Eurofins Amatsigroup after several months of training and in- depth testing in order to use the software in an expert mode.
Description:
Category: Analytical
Type: Small Molecules
Contact: Nicolas Leroy ([email protected])